Evidence map›Paper›PMID 35566292›Full record

ReviewMolecules (Basel, Switzerland)2022

The Lactoferrin Phenomenon-A Miracle Molecule.

Paweł Kowalczyk, Katarzyna Kaczyńska, Patrycja Kleczkowska, Iwona Bukowska-Ośko, Karol Kramkowski, Dorota Sulejczak

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 72 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed, 1 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05936528 phase4completednot on this mapstarted 2025, after this paper: background citation

The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients

TypeinterventionalSponsorMansoura University HospitalRan2025 to 2026Enrolled660ConditionsCritical IllnessArmsLactoferrin, Antioxidant therapies, Dexamethasone, Antibacterial therapies
NCT07524270 narecruitingnot on this mapstarted 2026, after this paper: background citation

Dose-Response of Effera® Supplementation for Women's Health Outcomes

TypeinterventionalSponsorHelaina Inc.Ran2026 to 2026Enrolled160ConditionsWomens Health, Menstrual SymptomsArmsEffera® (human equivalent lactoferrin), Placebo
3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 1 synthesis or guideline pooled it, 159 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Metal uptake systems underpinInfection and immunity · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Paweł KowalczykDepartment of Animal Nutrition, The Kielanowski Institute of Animal Physiology and Nutrition, Polish Academy of Sciences, 05-110 Jabłonna, Poland.ORCID 0000-0003-4025-3750
Katarzyna KaczyńskaDepartment of Respiration Physiology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.ORCID 0000-0001-9608-4736
Patrycja KleczkowskaMaria Sklodowska-Curie, Medical Academy in Warsaw, Solidarności 12 St., 03-411 Warsaw, Poland.ORCID 0000-0002-8389-0920
Iwona Bukowska-OśkoDepartment of Immunopathology of Infectious and Parasitic Diseases, Medical University of Warsaw, Pawinskiego 3c St., 02-106 Warsaw, Poland.ORCID 0000-0002-0216-7184
Karol KramkowskiDepartment of Physical Chemistry, Medical University of Bialystok, Kilińskiego 1 St., 15-089 Bialystok, Poland.
Dorota SulejczakDepartment of Experimental Pharmacology, Mossakowski Medical Research Institute, Polish Academy of Sciences, Pawińskiego 5 St., 02-106 Warsaw, Poland.ORCID 0000-0002-1697-8164
Mossakowski Medical Research Institute, Polish Academy of Sciences · PLKielanowski Institute of Animal Physiology and Nutrition · PLMedical University of Białystok · PLMedical University of Warsaw · PLWojskowy Instytut Higieny i Epidemiologii · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous harmful factors that affect the human body from birth to old age cause many disturbances, e.g., in the structure of the genome, inducing cell apoptosis and their degeneration, which leads to the development of many diseases, including cancer. Among the factors leading to pathological processes, microbes, viruses, gene dysregulation and immune system disorders have been described. The function of a protective agent may be played by lactoferrin as a "miracle molecule", an endogenous protein with a number of favorable antimicrobial, antiviral, antioxidant, immunostimulatory and binding DNA properties. The purpose of this article is to present the broad spectrum of properties and the role that lactoferrin plays in protecting human cells at all stages of life.

Indexed as

VirusesHumansImmune SystemLactoferrinLactoferrinLTF protein, humanagingcancerimmunomodulationlactoferrinoxidative stress

Identifiers

PMID35566292
PMCPMC9104648
OpenAlexW4229075517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.